PHAXIAM Therapeutics SA (PHXM) Cash From Financing

Annual CFF

-$1.86 M
-$54.77 M-103.52%

December 31, 2022

Summary

Performance

1-Year Change

-103.52%

3-Year Change

-4261.83%

5-Year Change

-100.93%

15-Year Change

-100.93%

PHXM Cash From Financing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$201.07 M
PHXM annual cash flow from financing activities is currently -100.93% below its historical high of $201.07 million

3-Year Low

-$1.86 M
PHXM annual cash flow from financing activities is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
PHXM previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
PHXM next annual earnings announcement has not yet been scheduled

OtherPHXMcash flowmetrics:

Annual CFI

$40.21 M
PHXM annual cash flow from investing activities is $40.21 million

Annual CFO

-$33.50 M
PHXM annual cash flow from operations is -$33.50 million

Annual FCF

-$33.59 M
PHXM annual free cash flow is -$33.59 million

Annual CAPEX

-
PHXM annual capital expenditures value is unknown

Quarterly CFF

N/A

September 30, 2023

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

PHXM Quarterly CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$41.04 M
PHXM quarterly cash flow from financing activities is currently at an all-time high

3-Year Low

$2.12 M
PHXM quarterly cash flow from financing activities is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2023
PHXM previous earnings announcement was published on Sep 30, 2023

Next Quarterly Earnings Report Date

N/A
PHXM next earnings announcement has not yet been scheduled

OtherPHXMcash flowmetrics:

Quarterly CFI

-
PHXM quarterly cash flow from investing activities value is unknown

Quarterly CFO

-
PHXM quarterly cash flow from operations value is unknown

Quarterly FCF

-
PHXM quarterly free cash flow value is unknown

Quarterly CAPEX

-
PHXM quarterly capital expenditures value is unknown

TTM CFF

N/A

September 30, 2023

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

PHXM TTM CFF Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$41.04 M
PHXM TTM cash flow from financing activities is currently at an all-time high

3-Year Low

$2.12 M
PHXM TTM cash flow from financing activities is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2023
PHXM previous earnings announcement was published on Sep 30, 2023

Next Quarterly Earnings Report Date

N/A
PHXM next earnings announcement has not yet been scheduled

OtherPHXMcash flowmetrics:

TTM CFI

-
PHXM TTM cash flow from investing activities value is unknown

TTM CFO

-
PHXM TTM cash flow from operations value is unknown

TTM FCF

-
PHXM TTM free cash flow value is unknown

TTM CAPEX

-
PHXM TTM capital expenditures value is unknown

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

PHXM Cash From Financing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-103.5%--
3 y3 years-4261.8%--
5 y5 years-100.9%--

PHXM Cash From Financing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-103.5%at low
5 y5-year-103.5%at low
alltimeall time-100.9%at low

PHAXIAM Therapeutics SA Cash From Financing History

DateAnnualQuarterlyTTM
Dec 2022
-$1.86 M(-103.5%)
-
-
Jun 2022
-
$2.12 M(-94.8%)
$2.12 M(-94.8%)
Dec 2021
$52.90 M(+82.0%)
-
-
Jun 2021
-
$41.04 M(+1551.9%)
$41.04 M(+1311.3%)
Dec 2020
$29.06 M(>+9900.0%)
-
-
Jun 2020
-
$2.48 M(+486.5%)
$2.91 M(+112.4%)
Dec 2019
$44.80 K
-
-
Sep 2019
-
$423.60 K(-55.2%)
$1.37 M(+272.1%)
DateAnnualQuarterlyTTM
Jun 2019
-
$945.90 K(-263.7%)
$368.00 K(-163.7%)
Dec 2018
-$965.90 K(-100.5%)
-
-
Sep 2018
-
-$577.90 K
-$577.90 K
Dec 2017
$201.07 M(+1494.6%)
-
-
Dec 2016
$12.61 M(-51.7%)
-
-
Dec 2015
$26.10 M(-33.6%)
-
-
Dec 2014
$39.29 M(+111.3%)
-
-
Dec 2013
$18.59 M(+187.0%)
-
-
Dec 2012
$6.48 M
-
-

FAQ

  • What is PHAXIAM Therapeutics SA annual cash flow from financing activities?
  • What is the all time high annual CFF for PHAXIAM Therapeutics SA?
  • What is PHAXIAM Therapeutics SA annual CFF year-on-year change?
  • What is the all time high quarterly CFF for PHAXIAM Therapeutics SA?
  • What is the all time high TTM CFF for PHAXIAM Therapeutics SA?

What is PHAXIAM Therapeutics SA annual cash flow from financing activities?

The current annual CFF of PHXM is -$1.86 M

What is the all time high annual CFF for PHAXIAM Therapeutics SA?

PHAXIAM Therapeutics SA all-time high annual cash flow from financing activities is $201.07 M

What is PHAXIAM Therapeutics SA annual CFF year-on-year change?

Over the past year, PHXM annual cash flow from financing activities has changed by -$54.77 M (-103.52%)

What is the all time high quarterly CFF for PHAXIAM Therapeutics SA?

PHAXIAM Therapeutics SA all-time high quarterly cash flow from financing activities is $41.04 M

What is the all time high TTM CFF for PHAXIAM Therapeutics SA?

PHAXIAM Therapeutics SA all-time high TTM cash flow from financing activities is $41.04 M